VerImmune
Blood & Organ Banks · District of Columbia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7144 13th St NW Ste 2200, Washington, Di...Website
www.verimmune.comRevenue
<$5 MillionIndustry
About VerImmune
VerImmune is pioneering a breakthrough therapy known as Anti-Tumor Immune Redirection (AIR), which aims to redirect immune memory from pathogens or childhood vaccines to target cancer. The company focuses on leveraging pre-existing immune memory to enhance cancer treatment, leading to tumor cell death. With over 14 million new cancer cases annually and significant spending on cancer care, VerImmune addresses a critical need in the healthcare industry. Their strategy includes patient selection based on pre-existing immunity and modifying tumor cells to mimic viral infections, facilitating an effective immune response.Explore more
VerImmune Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to VerImmune
Compare insights from companies similar to VerImmune, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
VerImmune Tech Stack
A closer look at the technologies used by VerImmune
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VerImmune
Sign Up For FreeTo access detailed company insights
VerImmune is pioneering a breakthrough therapy known as Anti-Tumor Immune Redirection (AIR), which aims to redirect immune memory from pathogens or childhood vaccines to target cancer. The company focuses on leveraging pre-existing immune memory to enhance cancer treatment, leading to tumor cell death. With over 14 million new cancer cases annually... Read More
